References
- 1. Gearhart PA, Randall TC, Buckley RM, Higgins RV. Human Papillomavirus (HPV). [Internet]. Medscape [updated Feb 20, 2020]. Available from: https://emedicine.medscape.com/article/219110-overview.
- 2. Sarafoleanu C. Tumorile benigne ale laringelui. In: Popescu I, Ciuce C (eds); Sarafoleanu C (coord). Tratat de chirurgie. Editia a II-a. Vol I.: Otorinolaringologie si chirurgie cervico-faciala. Editura Academiei Romane, Bucuresti; 2012, p.199–217.
- 3. Gheorghe DC. Patologia laringiana pediatrica. In: Popescu I, Ciuce C (eds); Sarafoleanu C (coord). Tratat de chirurgie. Editia a II-a. Vol I.: Otorinolaringologie si chirurgie cervico-faciala. Editura Academiei Romane, Bucuresti; 2012, p.568–601.
- 4. McCane DJ. Papillomaviruses. In: Zuckermann AJ, Banatvala JE, Pattison JR (eds). Principles and practice of clinical virology. Fourth Edition. John Wiley & Sons Ltd; 2000, p.607–18. DOI: 10.1002/0470842474.ch22.10.1002/0470842474.ch22
- 5. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17–27.10.1016/j.virol.2004.03.033
- 6. Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121(12):1386–91. DOI: 10.1001/archotol.1995.
- 7. Chow VT, Leong PWF. Complete nucleotide sequence, genomic organization and phylogenetic analysis of a novel genital human papillomavirus type, HLT7474-S. J Gen Virol. 1999;80(Pt 11):2923–9. DOI: 10.1099/0022-1317-80-11-2923.10.1099/0022-1317-80-11-2923
- 8. Farmer AD, Calef CE, Millman K, Myers GL. The human papillomavirus database. J Biomed Sci. 1995;2(2):90–104.10.1007/BF02253061
- 9. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.10.1056/NEJMoa021641
- 10. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110(5):525–41.10.1042/CS20050369
- 11. Hebner CM, Laimins LA. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol. 2006;16(2):83–97.10.1002/rmv.488
- 12. Durst M, Kleinheinz A, Hotz M, Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol. 1985;66(Pt 7):1515–22.10.1099/0022-1317-66-7-1515
- 13. Lehoux M, D’Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced caricnogenesis. Public Health Genomics. 2009;12(5–6):268–80. DOI: 10.1159/000214918.10.1159/000214918
- 14. Hoory T, Monie A, Gravitt P, Wu TC. Molecular epidemiology of human papillomavirus. J Formos Med Assoc. 2008;107(3):198–217. DOI: 10.1016/S0929-6646(08)60138-2.10.1016/S0929-6646(08)60138-2
- 15. Egawa K. Do human papillomaviruses target epidermal stem cells? Dermatology. 2003;207(3):251–4. DOI: 10.1159/000073085.10.1159/00007308514571065
- 16. Gravitt PE. Evidence and impact of human papillomavirus latency. Open Virol J. 2012;6:198–203. DOI: 10.2174/1874357901206010198.10.2174/1874357901206010198354738523341855
- 17. Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropism, and the development of neoplasia. Viruses. 2015;7(7):386–90. DOI: 10.3390/v7072802.10.3390/v7072802451713126193301
- 18. Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, et al. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol. 2004;65(8):773–82. DOI: 10.1016/j.humimm.2004.05.014.10.1016/j.humimm.2004.05.01415336778
- 19. Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, et al. HLA class II polymorphism amd susceptibility to recurrent respiratory papillomatosis. J Virol. 2003;77(3):1927–39. DOI: 10.1128/JVI.77.3.1927-1939.2003.10.1128/JVI.77.3.1927-1939.2003
- 20. Snowden RT, Thomson J, Horwitz E, Stocks RM. The prediction value of serum interleukins in recurrent respiratory papillomatosis: a preliminary study. Laryngoscope. 2001;111(3):404–8.10.1097/00005537-200103000-0000711224768
- 21. Williams OM, Hart KW, Wang ECY, Geller CM. Analysis of CD4+ T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types. J Virol. 2002;76(15):7418–29. DOI: 10.1128/JVI.76.15.7418-7429.2002.10.1128/JVI.76.15.7418-7429.2002
- 22. Hatam LJ, DeVoti JA, Rosenthal DW, Lam F, Abramson AL, Steinberg BM, et al. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression. Clin Cancer Res. 2012;18(7):1925–35.10.1158/1078-0432.CCR-11-2941331985122322668
- 23. Ahn J, Bishop JA, Roden RBS, Allen CT, Best SRA. The PD-1and PD-L1 pathway in recurrent respiratory papillomatosis. Laryngoscope. 2018;128(1):E27–32. DOI: 10.1002/lary.26847.10.1002/lary.26847577144128940446
- 24. Escobedo AR, Santillana KMS, Gonzalez JLT. Recurrent respiratory papillomatosis: review and treatment update. J Otolaryngol Rhinol. 2018;4:040. DOI: 10.23937/2572-4193.1510040.10.23937/2572-4193.1510040
- 25. Derkay CS, Hester RP, Burke B, Carron J, Lawson L. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2004;68(12):1493–8.10.1016/j.ijporl.2004.06.00715533560
- 26. Ivancic R, Iqbal H, deSilva B, Pan Q, Matrka L. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2018;3(1):22–34. DOI: 10.1002/lio2.132.10.1002/lio2.132582410629492465
- 27. Bonagura VR, Hatam LJ, Rosenthal DW, de Voti JA, Lam F, Steinberg BM, et al. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS. 2010;118(6–7):455–70. DOI: 10.1111/j.1600-0463.2010.02617.x.10.1111/j.1600-0463.2010.02617.x290966520553528
- 28. DeVoti J, Hatam L, Lucs A, Afzal A, Abramson A, Steinberg B, et al. Decreased Langerhans cell responses to IL-36gamma: altered innate immunity in patients with recurrent respiratory papillomatosis. Mol Med. 2014;20:372–80. DOI: 10.2119/molmed.2014.00098.10.2119/molmed.2014.00098415383824950037
- 29. Rhea WG Jr, Bourgeois BM, Sewell DR. Condyloma acuminata: a fatal disease? Am Surg. 1998;64(11):1082–7.
- 30. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29(1):1–9.10.1016/j.jaut.2007.05.002271701517582741
- 31. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3–4):197–207. DOI: 10.1016/j.jaut.2009.09.008.10.1016/j.jaut.2009.09.008278342219819109
- 32. Chandrashekara S. The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review. Indian J Pharmacol. 2012;44(6):665–71. DOI: 10.4103/0253-7613.103235.10.4103/0253-7613.103235352348923248391
- 33. Rosenblum MD, Gratz IK, Paw JS, Abbas AK. Treating human autoimmunity: current practice and future prospects. Sci Transl Med. 2012;4(125):125sr1. DOI: 10.1126/scitranslmed.3003504.10.1126/scitranslmed.3003504406198022422994
- 34. Hall BM. Corticosteroids in autoimmune diseases. Aust Prescr. 1999;22:9–11. DOI: 10.18773/austprescr.1999.008.10.18773/austprescr.1999.008
- 35. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Enlg J Med. 1995;333(15):958–63.10.1056/NEJM1995101233315027666914
- 36. de Winter BCM, van Gelder T. Therapeutic drug monitoring for mycophenolic acid in patients with autoimmune disease. Nephrol Dial Transplant. 2008;23(11):3386–8. DOI: 10.1093/ndt/gfn497.10.1093/ndt/gfn49718780901
- 37. Zeina B, Sakka N, Mansoor S. Pemphigus vulgaris. [Internet]. Medscape [updated Jun 14,2018]. Available online: https://emedicine.medscape.com/article/1064187-overview#a6.
- 38. Fitzpatrick RE, Newcomer VD. The correlation of disease activity and antibody titers in pemphigus. Arch Dermatol. 1980;116(3):285–90.10.1001/archderm.1980.01640270045011
- 39. Lombardi ML, Mercuro O, Ruocco V, Lo Schiavo A, Lombari V, Guerrera V, et al. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol. 1999;113(1):107–10.10.1046/j.1523-1747.1999.00626.x10417627
- 40. Heelan K, Al-Mohammedi F, Smith MJ, Knowles S, Lansang P, Walsh S, et al. Durable remission of pemphigus with fixed-dose rituximab protocol. JAMA Dermatol. 2014;150(7):703–8. DOI: 10.1001/jamadermatol.2013.6739.10.1001/jamadermatol.2013.673924500264
- 41. Wang Y, Shang Q, Xu W, Di L, Gu H, Wei L. Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein. Diagn Pathol. 2014;9:101. DOI: 10.1186/1746-1596-9-101.10.1186/1746-1596-9-101409914624884993
- 42. Mohr M, Schliemann C, Biermann C, Schmidt LH, Kessler T, Schmidt J, et al. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol Lett. 2014;8(5):1912–8. DOI: 10.3892/ol.2014.248610.3892/ol.2014.2486418657825289079